ARL14 and breast cancer: Further analysis of the methylation sites showed that the hypermethylation of 5 sites in LURAP1 and GSTM2 is associated with better prognosis, and the hypermethylation of another 9 sites in ARHGDIB, LINC00526 and ARL14 is associated with poor prognosis in BC.